Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Hiroki Watanabe(Kyoto University), Kazuya Kawai(Chikamori Hospital), Masaharu Akao(Kyoto Medical Center), Yasuhiko Hayashi(Kindai University Hospital), Shuichiro Kaji(Kansai Electric Power Hospital), Kiyoshi Hibi(Yokohama City University Medical Center), Masaaki Okutsu(Fukuoka Tokushukai Hospital), Bingyuan Bao(Kyoto University), Mamoru Nanasato(Japanese Red Cross Nagoya Daini Hospital), Mitsunori Abe(Matsuyama University), Yutaka Furukawa(Kobe City Medical Center General Hospital), Shigeru Ikeguchi(Shiga Medical Center), Hiroki Shiomi(Kyoto University), Satoru Suwa(Juntendo University Shizuoka Hospital), Yoichi Sugimura(Showa General Hospital), Kazushige Kadota(Kurashiki Central Hospital), Sunao Nakamura(New Tokyo Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Tsukasa Inada(Osaka Red Cross Hospital), Ryosuke Kametani(Yao Tokushukai General Hospital), Takahiko Suzuki(Toyohashi Heart Center), Takahito Sone(Ogaki Municipal Hospital), Hironori Kaneko(Toho University), Chisato Izumi(National Cerebral and Cardiovascular Center), Neiko Ozasa(Kyoto University), Takeshi Kimura(Saiseikai Yokohama Eastern Hospital)
PLoS ONE
August 28, 2018
Cited by 128


Related Papers